Paperpal Prime Logo

Drug Development Research : Impact Factor & More

eISSN: 1098-2299pISSN: 0272-4391

Key Metrics

CiteScore
5.2
H-Index
65
Impact Factor
< 5
SJR
Q2Drug Discovery
SNIP
0.89
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Drug Development Research

Drug Development Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1981
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Drug Development Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your researchless than 30 sec
Free Report

Recently Published Papers in Drug Development Research

Luliconazole Potentiates Efficacy of Miltefosine Against Leishmania donovani.
  • 1 Aug 2026
  • Drug development research
TrxR Inhibition and Nrf2-FOXO3 Modulation by Repurposed Drugs: A Redox Strategy to Reverse Cancer Multidrug Resistance.
  • 1 Aug 2026
  • Drug development research
Benzimidazole-Based VEGFR-2 Inhibitors Inspired by Sorafenib: Synthesis, Biological Evaluation, and Mechanistic Insights.
  • 1 Aug 2026
  • Drug development research
RETRACTION: Reprogramming the Tumor Microenvironment: Calebin A as a Polyphenolic Paradigm Shift in Controlling Inflammation, Stemness, and Resistance in Colorectal Cancer.
  • 1 Aug 2026
  • Drug development research
Structure-Based Design, Synthesis, and Biological Evaluation of Oxadiazole-Morpholine Hybrids as Potent PARP-1 Inhibitors Inducing Apoptosis in Breast Cancer Cells.
  • 1 Aug 2026
  • Drug development research
The Expanding Role of Indole Scaffolds in Combating Antimicrobial Resistance.
  • 1 Aug 2026
  • Drug development research
Luliconazole Potentiates Efficacy of Miltefosine Against Leishmania donovani.
  • 1 Aug 2026
  • Drug development research
TrxR Inhibition and Nrf2-FOXO3 Modulation by Repurposed Drugs: A Redox Strategy to Reverse Cancer Multidrug Resistance.
  • 1 Aug 2026
  • Drug development research
Benzimidazole-Based VEGFR-2 Inhibitors Inspired by Sorafenib: Synthesis, Biological Evaluation, and Mechanistic Insights.
  • 1 Aug 2026
  • Drug development research
RETRACTION: Reprogramming the Tumor Microenvironment: Calebin A as a Polyphenolic Paradigm Shift in Controlling Inflammation, Stemness, and Resistance in Colorectal Cancer.
  • 1 Aug 2026
  • Drug development research
Structure-Based Design, Synthesis, and Biological Evaluation of Oxadiazole-Morpholine Hybrids as Potent PARP-1 Inhibitors Inducing Apoptosis in Breast Cancer Cells.
  • 1 Aug 2026
  • Drug development research
The Expanding Role of Indole Scaffolds in Combating Antimicrobial Resistance.
  • 1 Aug 2026
  • Drug development research
View all papers for this journal

FAQs on Drug Development Research

Global Journal Library:

Paperpal Prime logo

Cactus Communications Services Pte Ltd
20 McCallum Street, #19-01, Tokio Marine Centre, Singapore 069046

We are with you every step of the way as you achieve your dreams - publication, everything that precedes it, and everything that comes after. You are much more than your last research project. It’s time you got more.

Instagram icon

USEFUL LINKS

EXCITED ABOUT RESEARCHER.LIFE?

We are always looking for inspiration, feedback, and collaborators

Write to us

Copyright 2026 Cactus Communications. All rights reserved.

Privacy PolicyCookies PolicyTerms of UseCareers
Check if your manuscript is a good match for
undefined

Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript


word doc icon
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages

Do not have a manuscript right now? Use an abstract or summary

Your document is 100% secure & confidential

We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified

What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations